Home » Topics » Regulatory

Regulatory
RSS

Novartis receives approvable letter for Diovan as treatment for heart failure

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

FDA grants expedited approval for Protonix I.V. in Zollinger-Ellison syndrome Rx

Oct. 24, 2001

Gleevec submitted for FDA review in gastrointestinal tumors

Oct. 24, 2001

Approval of Xeloda for treatment of breast cancer recommended in E.U.

Oct. 23, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 25, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 25, 2025.
Medtronic expects its Hugo robotic system set to drive future growth
BioWorld MedTech
Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S. FDA approval. Already approved for use...
SHCBP1 is triple-negative breast cancer driver, potential target
BioWorld Science
Triple-negative breast cancer (TNBC) accounts for a substantial proportion of all breast cancers and is the most aggressive form of the disease. Identifying...
TIPE2 is prognostic marker in colorectal cancer
BioWorld MedTech
Colorectal cancer is among the most common malignant tumor types and the second leading cause of tumor-related deaths worldwide. Tumor necrosis factor α-induced...